Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.900
+0.130 (7.34%)
At close: Jun 26, 2026, 4:00 PM EDT
1.941
+0.041 (2.14%)
After-hours: Jun 26, 2026, 4:56 PM EDT
Health Catalyst Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 2.28, with a low estimate of 1.75 and a high estimate of 3.00. The average target predicts an increase of 20.00% from the current stock price of 1.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Health Catalyst stock from 7 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 7 | 7 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 9 | 9 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $1 → $1.75 | Hold | Maintains | $1 → $1.75 | -7.89% | Jun 26, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2 | Buy | Maintains | $2 | +5.26% | Jun 5, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 4, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Hold Maintains $2 | Hold | Maintains | $2 | +5.26% | May 12, 2026 |
| Stephens | Stephens | Hold Maintains $2 → $1.75 | Hold | Maintains | $2 → $1.75 | -7.89% | May 12, 2026 |
Financial Forecast
Revenue This Year
263.11M
from 311.14M
Decreased by -15.43%
Revenue Next Year
246.77M
from 263.11M
Decreased by -6.21%
EPS This Year
0.04
from 0.18
Decreased by -76.66%
EPS Next Year
0.09
from 0.04
Increased by 119.66%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 265.0M | 271.0M | |
| Avg | 263.1M | 246.8M | |
| Low | 260.7M | 232.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -14.8% | 3.0% | |
| Avg | -15.4% | -6.2% | |
| Low | -16.2% | -11.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.22 | 0.52 | |
| Avg | 0.04 | 0.09 | |
| Low | -0.05 | -0.07 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 22.2% | 1,137.5% | |
| Avg | -76.7% | 119.7% | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.